• Report details
  • 14 Figures
  • 32 Tables
  • Tariffs Heighten Uncertainty for Instrument Firms
  • Executive Briefing
    • QIAGEN Raises FY Guidance
    • Bruker Q1 Results Meet Forecasts
    • PacBio Announces Preliminary Results and Workforce Reductions
    • Sartorius Invests in Microtissues
    • Tecan to Acquire Certain Assets from Revvity
    • Investors Express Further Opposition to Quanterix-Akoya
    • 908 Devices Announces Preliminary Results
    • Refurbished Equipment Supplier Acquired
  • Fourth Quarter Results: 10x Genomics, HORIBA, Oxford Nanopore, QIAGEN and Tecan
    • 10x Genomics Predicts a Modest 2025 Performance
      • Q4
      • FYE
    • HORIBA Records Mixed Results in Europe
      • Q4
      • FYE
    • Oxford Nanopore Posts Broad-Based Growth by Market and Region
      • H2
      • FYE
    • QIAGEN Surpasses Annual Sales Forecast for 2024
      • Q4
      • FYE
    • Tecan Impacted by Various Weak Market Conditions
      • H2
      • FYE
  • Market Profile: Spectral Flow Cytometry
    • Leading Vendors
    • Largest Markets
    • Instrument Cost
  • Industry Watch
    • Government and R&D: NIH Indirect Cost Limit Stayed
    • Clinical: Court Vacates LDT Rule
    • Government and Biopharma: FDA Endorses Non-Animal Testing
  • Region Watch
    • UK: Government Releases DSIT Funding Numbers
    • China: OECD Releases Latest R&D Figures
    • EU: EU Updates Toy Regulations
  • News
    • Broad-Based Companies
      • Company Announcements
    • Life Science Instruments
      • Company Announcements
      • Gene-Based Analysis
      • Company Announcements
      • Product Introduction
      • Sales & Orders of Note
      • Cell-Based Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
      • Protein-Based Analysis
      • Company Announcements
      • Product Introductions
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales of Note
    • Bioprocess Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
  • Bottom Line
Instrument Business Outlook Volume 34 - Issue 1
15 Apr 2025

Request Access
 
Table of Contents
  • Tariffs Heighten Uncertainty for Instrument Firms
  • Executive Briefing
    • QIAGEN Raises FY Guidance
    • Bruker Q1 Results Meet Forecasts
    • PacBio Announces Preliminary Results and Workforce Reductions
    • Sartorius Invests in Microtissues
    • Tecan to Acquire Certain Assets from Revvity
    • Investors Express Further Opposition to Quanterix-Akoya
    • 908 Devices Announces Preliminary Results
    • Refurbished Equipment Supplier Acquired
  • Fourth Quarter Results: 10x Genomics, HORIBA, Oxford Nanopore, QIAGEN and Tecan
    • 10x Genomics Predicts a Modest 2025 Performance
      • Q4
      • FYE
    • HORIBA Records Mixed Results in Europe
      • Q4
      • FYE
    • Oxford Nanopore Posts Broad-Based Growth by Market and Region
      • H2
      • FYE
    • QIAGEN Surpasses Annual Sales Forecast for 2024
      • Q4
      • FYE
    • Tecan Impacted by Various Weak Market Conditions
      • H2
      • FYE
  • Market Profile: Spectral Flow Cytometry
    • Leading Vendors
    • Largest Markets
    • Instrument Cost
  • Industry Watch
    • Government and R&D: NIH Indirect Cost Limit Stayed
    • Clinical: Court Vacates LDT Rule
    • Government and Biopharma: FDA Endorses Non-Animal Testing
  • Region Watch
    • UK: Government Releases DSIT Funding Numbers
    • China: OECD Releases Latest R&D Figures
    • EU: EU Updates Toy Regulations
  • News
    • Broad-Based Companies
      • Company Announcements
    • Life Science Instruments
      • Company Announcements
      • Gene-Based Analysis
      • Company Announcements
      • Product Introduction
      • Sales & Orders of Note
      • Cell-Based Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
      • Protein-Based Analysis
      • Company Announcements
      • Product Introductions
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales of Note
    • Bioprocess Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
  • Bottom Line
Categories
To the Top
More information about this product
Other Users Also Viewed
2025 PET Market Summary Report
5 Mar 2025
PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing…
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition
29 Aug 2024
IVD Test Procedure Volumes, 2024-2029
8 Oct 2024
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
6 Jun 2023
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
1 Apr 2011